Malvidin-3-galactoside chloride是一种花青素单体，具有抗氧化活性。
Cas No.:30113-37-2
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Malvidin-3-galactoside chloride is an anthocyanin monomer that possesses antioxidant activity[1-2]. Malvidin-3-galactoside chloride is used in research related to cancer, cardiovascular diseases, and intestinal microbiota regulation[3-4].
In vitro, human retinal capillary endothelial cells (HRCECs) were pretreated with Malvidin-3-galactoside chloride (10µg/mL) for 24 hours, followed by stimulation with high glucose (30mmol/L) for 24-48 hours. Malvidin-3-galactoside chloride significantly reduced reactive oxygen species levels, increased the activity of antioxidant enzymes (CAT, SOD), downregulated Nox4 expression, altered nitric oxide levels, while also inhibiting vascular endothelial growth factor production and lowering intercellular adhesion molecule-1 levels, thereby exerting antioxidant and anti-inflammatory effects to protect the cells[5]. Human umbilical vein endothelial cells (HUVECs) were pretreated with Malvidin-3-galactoside chloride (1–100µM) for 18 hours, followed by stimulation with TNF-α (10µg/L) for 6 hours. Malvidin-3-galactoside chloride significantly and concentration-dependently inhibited the expression of monocyte chemoattractant protein-1, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 at both the protein and mRNA levels, while also inhibiting IκBα degradation and blocking the nuclear translocation of the p65 protein[6].
In vivo, C57BL/6J male mice subcutaneously injected with human hepatocellular carcinoma HepG2 cells were administered Malvidin-3-galactoside chloride (40mg/kg or 80mg/kg) via oral gavage every other day for 4 consecutive weeks. Malvidin-3-galactoside chloride significantly inhibited tumor growth, promoted tumor cell apoptosis, inhibited cell proliferation, and upregulated PTEN expression while downregulating p-AKT expression in the tumor tissues[7].
References:
[1] Jie Lin, Jinlong Tian, Chi Shu, et al. Malvidin-3-galactoside from blueberry suppresses the growth and metastasis potential of hepatocellular carcinoma cell Huh-7 by regulating apoptosis and metastases pathway. Food Science and Human Wellness. 2020;9(2):136-145.
[2] Rutledge GA, Sandhu AK, Miller MG, et al. Blueberry phenolics are associated with cognitive enhancement in supplemented healthy older adults. Food Funct. 2021 Jan 7;12(1):107-118.
[3] Huang WY, Wu H, Li DJ, et al. Protective Effects of Blueberry Anthocyanins against H2O2-Induced Oxidative Injuries in Human Retinal Pigment Epithelial Cells. J Agric Food Chem. 2018 Feb 21;66(7):1638-1648.
[4] Huang W, Zhu Y, Li C, et al. Effect of Blueberry Anthocyanins Malvidin and Glycosides on the Antioxidant Properties in Endothelial Cells. Oxid Med Cell Longev. 2016;2016:1591803.
[5] Huang W, Yan Z, Li D, et al. Antioxidant and Anti-Inflammatory Effects of Blueberry Anthocyanins on High Glucose-Induced Human Retinal Capillary Endothelial Cells. Oxid Med Cell Longev. 2018 Feb 22;2018:1862462.
[6] Huang WY, Liu YM, Wang J, et al. Anti-inflammatory effect of the blueberry anthocyanins malvidin-3-glucoside and malvidin-3-galactoside in endothelial cells. Molecules. 2014 Aug 21;19(8):12827-41.
[7] Wang Y, Lin J, Tian J, et al. Blueberry Malvidin-3-galactoside Suppresses Hepatocellular Carcinoma by Regulating Apoptosis, Proliferation, and Metastasis Pathways In Vivo and In Vitro. J Agric Food Chem. 2019 Jan 16;67(2):625-636.
Malvidin-3-galactoside chloride是一种花青素单体，具有抗氧化活性[1-2]。Malvidin-3-galactoside chloride可用于癌症、心血管疾病和肠道菌群调节的相关研究[3-4]。
在体外，Malvidin-3-galactoside chloride（10μg/mL）预处理人视网膜毛细血管内皮细胞（HRCECs）24小时，随后以高葡萄糖（30mmol/L）刺激24-48小时。Malvidin-3-galactoside chloride显著降低活性氧水平、提高抗氧化酶（CAT、SOD）活性、下调Nox4表达并改变一氧化氮水平，同时抑制血管内皮生长因子产生、降低细胞间黏附分子-1水平，从而发挥抗氧化和抗炎作用以保护细胞[5]。Malvidin-3-galactoside chloride（1–100µM）预处理人脐静脉内皮细胞（HUVECs）18小时，随后以TNF-α（10µg/L）刺激6小时。Malvidin-3-galactoside chloride能以浓度依赖的方式显著抑制单核细胞趋化蛋白-1、细胞间黏附分子-1和血管细胞黏附分子-1在蛋白和mRNA水平的表达，同时抑制IκBα的降解并阻断p65蛋白的核转位[6]。
在体内，隔天灌胃给予40mg/kg或80mg/kg的Malvidin-3-galactoside chloride，用于处理皮下注射了人肝癌HepG2细胞的C57BL/6J雄性小鼠，持续4周。Malvidin-3-galactoside chloride能显著抑制肿瘤生长、促进肿瘤细胞凋亡、抑制细胞增殖，并上调肿瘤组织中PTEN的表达同时下调p-AKT的表达[7]。
| Cell experiment [1]: | |
Cell lines | Human umbilical vein endothelial cells (HUVECs) |
Preparation Method | HUVECs were maintained in M199 medium supplemented with fetal bovine serum. Cells were pretreated with Malvidin-3-galactoside chloride (1, 10, 50, and 100µM) for 18 hours, followed by stimulation with Tumor Necrosis Factor-alpha (TNF-α; 10µg/L) for 6 hours. |
Reaction Conditions | 1-100µM; 18h pretreatment |
Applications | Malvidin-3-galactoside chloride inhibited TNF-α-induced increases in the production of monocyte chemotactic protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in a concentration-dependent manner, both at the protein and mRNA levels. Malvidin-3-galactoside chloride also decreased IκBα degradation and blocked the nuclear translocation of the p65 subunit, indicating its anti-inflammatory mechanism is mediated by blocking the Nuclear Factor-kappa B (NF-κB) pathway. |
| Animal experiment [2]: | |
Animal models | C57BL/6 mice |
Preparation Method | Mice were injected with 1 x 10⁶ HepG2 cells. Starting 1 week after injection, mice were administered Malvidin-3-galactoside chloride (40mg/kg or 80mg/kg) by gavage every other day for 4 consecutive weeks. A control group received distilled water. |
Dosage form | 40mg/kg or 80mg/kg; Oral gavage; Every other day for 4 weeks. |
Applications | Malvidin-3-galactoside chloride administration, particularly at 80mg/kg, significantly inhibited tumor growth, promoted tumor cell apoptosis, and inhibited cell proliferation. Malvidin-3-galactoside chloride also upregulated PTEN expression and downregulated p-AKT expression in tumor tissues. |
References: | |
| Cas No. | 30113-37-2 | SDF | |
| 别名 | 氯化锦葵色素-3-O-半乳糖苷 | ||
| 分子式 | C23H25ClO12 | 分子量 | 528.89 |
| 溶解度 | 储存条件 | Store at 2-8°C | |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.8908 mL | 9.4538 mL | 18.9075 mL |
| 5 mM | 378.2 μL | 1.8908 mL | 3.7815 mL |
| 10 mM | 189.1 μL | 945.4 μL | 1.8908 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet